| Rachel Yoshizu Gatewood, DPT | |
|
1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 | |
| (808) 433-5000 | |
| Not Available |
| Full Name | Rachel Yoshizu Gatewood |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1 Jarrett White Rd, Tripler Army Medical Center, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164653911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT60093136 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Yoshizu Gatewood, DPT 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: () - | Rachel Yoshizu Gatewood, DPT 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: (808) 433-5000 |
News Archive
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
The FDA on Monday announced the approval of the first drug for pre-exposure prophylaxis (PrEP) to prevent HIV among people at risk of contracting the virus, "which some are calling a landmark in the fight against AIDS," ABC News reports.
A team of zoologists and microbiologists from NUI Galway have published a new study showing that common house spiders carry bacteria susceptible to infect people, with the Noble False Widow spiders also carrying harmful strains resistant to common antibiotic treatments.
The American College of Physicians has announced that will present one of its highest honors, the Alvan R. Feinstein Memorial Award to William M. Tierney, M.D., president and C.E.O. of the Regenstrief Institute and the associate dean for clinical effectiveness research at the Indiana University School of Medicine.
While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.
› Verified 6 days ago
Devon Thomas, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-8031 | |
Tammy Tokuhara, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-4177 | |
Michelle Goldstein, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6200 | |
Dr. Nicholas James Wankum, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-5232 | |
Dr. John Brandon Canada, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-9013 | |
Kristy Arnold, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6661 |